Valneva annonce l’approbation par Santé Canada du premier vaccin au monde contre le chikungunya, IXCHIQ® Saint-Herblain (France), le 24 juin...
Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update Saint-Herblain (France...
VALNEVA - Declaration of shares and voting rights: May 31, 2024 VALNEVA Declaration of shares and voting rights May 31...
Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June Saint-Herblain (France), June 4, 2024 – Valneva SE (Nasdaq:...
Valneva annonce la publication de deux essais de Phase 2 sur la maladie de Lyme dans le Lancet Infectious Diseases Saint-Herblain (France), 3...
Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine If approved, IXCHIQ® will become the first vaccine available in the...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.